ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Deep Pharma Intelligence Ltd

Deep Pharma Intelligence Ltd is an active company incorporated on 2 November 2020 with the registered office located in London, Greater London. Deep Pharma Intelligence Ltd was registered 4 years ago.
Status
Active
Active since incorporation
Company No
12987888
Private limited company
Age
4 years
Incorporated 2 November 2020
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Due Soon
Dated 14 September 2024 (12 months ago)
Next confirmation dated 14 September 2025
Due by 28 September 2025 (15 days remaining)
Last change occurred 2 years 12 months ago
Accounts
Submitted
For period 1 Apr ⟶ 31 Mar 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 March 2025
Due by 31 December 2025 (3 months remaining)
Learn more about Deep Pharma Intelligence Ltd
Contact
Address
63-66 Hatton Garden
5th Floor, Suite 23
London
EC1N 8LE
England
Same address since incorporation
Telephone
07435 240477
Email
Unreported
Website
Dka.global
See All Contacts
People
Officers
1
Shareholders
2
Controllers (PSC)
1
Mr Ian James Inkster
Director • Consultant • Scottish • Lives in Scotland • Born in Nov 1983
Deep Knowledge Analytics Limited
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Biogerontology Research Foundation
Mr Ian James Inkster is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Mar 2024
For period 31 Mar ⟶ 31 Mar 2024
Traded for 12 months
Cash in Bank
£151
Decreased by £1.33K (-90%)
Turnover
Unreported
Same as previous period
Employees
1
Same as previous period
Total Assets
£317.98K
Decreased by £14.41K (-4%)
Total Liabilities
-£336.91K
Increased by £19.1K (+6%)
Net Assets
-£18.93K
Decreased by £33.51K (-230%)
Debt Ratio (%)
106%
Increased by 10.34% (+11%)
See 10 Year Full Financials
Latest Activity
Full Accounts Submitted
8 Months Ago on 31 Dec 2024
Confirmation Submitted
11 Months Ago on 25 Sep 2024
Full Accounts Submitted
1 Year 5 Months Ago on 28 Mar 2024
Confirmation Submitted
1 Year 12 Months Ago on 14 Sep 2023
Micro Accounts Submitted
2 Years 9 Months Ago on 2 Dec 2022
Alexei Cresniov Resigned
2 Years 11 Months Ago on 5 Oct 2022
Confirmation Submitted
2 Years 12 Months Ago on 14 Sep 2022
Confirmation Submitted
3 Years Ago on 31 Jul 2022
Accounting Period Extended
3 Years Ago on 25 Jul 2022
Confirmation Submitted
3 Years Ago on 21 Jan 2022
Get Alerts
Get Credit Report
Discover Deep Pharma Intelligence Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Total exemption full accounts made up to 31 March 2024
Submitted on 31 Dec 2024
Confirmation statement made on 14 September 2024 with no updates
Submitted on 25 Sep 2024
Total exemption full accounts made up to 31 March 2023
Submitted on 28 Mar 2024
Confirmation statement made on 14 September 2023 with no updates
Submitted on 14 Sep 2023
Micro company accounts made up to 31 March 2022
Submitted on 2 Dec 2022
Termination of appointment of Alexei Cresniov as a director on 5 October 2022
Submitted on 6 Oct 2022
Confirmation statement made on 14 September 2022 with updates
Submitted on 14 Sep 2022
Confirmation statement made on 31 July 2022 with updates
Submitted on 31 Jul 2022
Previous accounting period extended from 30 November 2021 to 31 March 2022
Submitted on 25 Jul 2022
Confirmation statement made on 21 January 2022 with updates
Submitted on 21 Jan 2022
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs